Orthopedic Disorders, Surgical Site Infection
Conditions
Keywords
Orthopedic surgery, Surgical site infection, Decolonization, Staphylococcus aureus
Brief summary
Surgical site infections are a major postoperative complication and are mostly due to colonization with endogenous germs, like Staphylococcus aureus, Staphylococcus epidermidis or Propionibacterium acnes. In literature, preoperative decolonization procedures showed a trend in lowering surgical site infection rates, but especially in orthopedic surgery data is controversial and randomized controlled trials are lacking. In the main study, the study investigators aim at performing a controlled prospective randomized interventional trial to measure the impact of preoperative decolonization of nasal Staphylococcus aureus carriers on surgical site infection rates in orthopedic surgery. In an alongside study a controlled prospective randomized interventional trial to measure the impact of preoperative skin decolonization of patients undergoing an orthopedic procedure will be conducted.
Detailed description
All participants will be assessed for eligibility during preoperative othopedic consultation. 2-3 weeks prior operation date participants will be screened for Staph. aureus carriage by nose-swab. According to nose-swab results randomizaton and allocation to study arm will be performed. After one and three months post-operatively participants will be asked by phone interview if surgical site infections occured. Results have to be confirmed by orthopedic surgeon if possible.
Interventions
Mupirocin nasal ointement 2x/d for 5 days preoperatively
Shower with Chlorhexidine sol 4% once a day for 5 days preoperatively
Sponsors
Study design
Eligibility
Inclusion criteria
* patient older than 16 years * patient undergoing elective orthopedic procedure at the Sonnenhof hospital * decolozination protocol can be performed timely * signed informed consent
Exclusion criteria
* no orthopedic surgery planned * allergy to mupirocin or chlorhexidine * presence of a nasal foreign body * no informed consent * pregnancy * decolozination protocol can't be followed timely * patients undergoing treatment/surgery for a documented infection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall number of participants with surgical site infections 3 months postoperatively | 3 months | Phone interview and orthopedic assessement |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants with surgical site infections at 1 and 3 months postoperatively | 1 and 3 months | Phone interview and orthopedic assessement |
Other
| Measure | Time frame | Description |
|---|---|---|
| Total screening costs | one year | Total screening costs divided by the number of prevented SSI to assess cost-effectiveness |
Countries
Switzerland